A novel anti-atherogenic role for COX-2—potential mechanism for the cardiovascular side effects of COX-2 inhibitors

This publication has 38 references indexed in Scilit:

• Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
  Proceedings of the National Academy of Sciences, 2006
• Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas
  Circulation, 2006
• Oral amphipathic peptides as therapeutic agents
  Expert Opinion on Investigational Drugs, 2005
• Diet and inflammation: a link to metabolic and cardiovascular diseases
  European Heart Journal, 2005
• Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂
  Science, 2002
• Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
  The American Journal of Pathology, 1999
• Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells
  The Journal of Experimental Medicine, 1998
• Prostaglandin synthase 2
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• Role of HDL Apolipoprotein E in Cellular Cholesterol Efflux: Studies in Apo E Knockout Transgenic Mice
  Biochemical and Biophysical Research Communications, 1994
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
  JAMA, 1986